Sign In
Buy MYCOF
$2.00
+0.240 (+13.64%)
At Close: Jun 09, 2026
Mydecine Innovations Group Earnings Calls
Mar 31, 2026
-$0.0717 (99.82%)
| Release date | May 28, 2026 |
| EPS estimate | -$40.24 |
| EPS actual | -$0.0717 |
| EPS Surprise | 99.82% |
| Revenue estimate | 239.761K |
| Revenue actual | - |
Dec 31, 2025
(Upcoming)
| Release date | Aug 17, 2026 |
| EPS estimate | -$0.394 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 15.75% |
Sep 30, 2025
$0.0427 (105.29%)
| Release date | May 27, 2026 |
| EPS estimate | -$0.81 |
| EPS actual | $0.0427 |
| EPS Surprise | 105.29% |
| Revenue estimate | - |
| Revenue actual | - |
Jun 30, 2025
| Release date | Jul 09, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0002 |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Mydecine Innovations Group
Below you can see how MYCOF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Jun 30, 2025
| Release date | Jul 09, 2025 |
| Price on release | $0.0028 |
| EPS estimate | - |
| EPS actual | -$0.0002 |
| Date | Price |
|---|---|
| Jul 02, 2025 | $0.0028 |
| Jul 03, 2025 | $0.140 |
| Jul 07, 2025 | $0.0065 |
| Jul 08, 2025 | $0.0028 |
| Jul 09, 2025 | $0.0028 |
| Jul 10, 2025 | $0.0028 |
| Jul 11, 2025 | $0.0053 |
| Jul 14, 2025 | $0.0027 |
| Jul 15, 2025 | $0.0030 |
| 4 days before | 0% |
| 4 days after | 7.14% |
| On release day | 0% |
| Change in period | 7.14% |
Sep 30, 2025
Beat
| Release date | May 27, 2026 |
| Price on release | $1.08 |
| EPS estimate | -$0.81 |
| EPS actual | $0.0427 |
| EPS surprise | 105.29% |
| Date | Price |
|---|---|
| May 20, 2026 | $1.08 |
| May 21, 2026 | $1.08 |
| May 22, 2026 | $1.08 |
| May 26, 2026 | $1.08 |
| May 27, 2026 | $1.08 |
| May 28, 2026 | $1.08 |
| May 29, 2026 | $1.08 |
| Jun 01, 2026 | $1.08 |
| Jun 02, 2026 | $1.08 |
| 4 days before | -0.343% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -0.343% |
Dec 31, 2025
(Upcoming)
| Release date | Aug 17, 2026 |
| Price on release | - |
| EPS estimate | -$0.394 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 03, 2026 | $1.08 |
| Jun 04, 2026 | $1.76 |
| Jun 05, 2026 | $1.76 |
| Jun 08, 2026 | $1.76 |
| Jun 09, 2026 | $2.00 |
Mar 31, 2026
Beat
| Release date | May 28, 2026 |
| Price on release | $1.08 |
| EPS estimate | -$40.24 |
| EPS actual | -$0.0717 |
| EPS surprise | 99.82% |
| Date | Price |
|---|---|
| May 21, 2026 | $1.08 |
| May 22, 2026 | $1.08 |
| May 26, 2026 | $1.08 |
| May 27, 2026 | $1.08 |
| May 28, 2026 | $1.08 |
| May 29, 2026 | $1.08 |
| Jun 01, 2026 | $1.08 |
| Jun 02, 2026 | $1.08 |
| Jun 03, 2026 | $1.08 |
| 4 days before | -0.343% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -0.343% |
Mydecine Innovations Group Earnings History
Earnings Calendar
FAQ
When is the earnings report for MYCOF?
Mydecine Innovations Group Inc. (MYCOF) has scheduled its earnings report for Aug 17, 2026 after the markets close.
What is the MYCOF price-to-earnings (P/E) ratio?
MYCOF P/E ratio as of Jun 09, 2026 (TTM) is 9.80.
What is the MYCOF EPS forecast?
The forecasted EPS (Earnings Per Share) for Mydecine Innovations Group Inc. (MYCOF) for the first fiscal quarter 2025 is -$0.394.
What are Mydecine Innovations Group Inc.'s retained earnings?
On its balance sheet, Mydecine Innovations Group Inc. reported retained earnings of $0 for the latest quarter ending Jun 30, 2028.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
